10-Q: Lightbridge Boosts Cash Reserves, Advances Nuclear Fuel R&D

Lightbridge Corporation significantly increased its cash position through equity offerings while expanding R&D activities and extending key national laboratory agreements for its advanced nuclear fuel.

Summary

• Cash and cash equivalents surged to $153.3 million as of September 30, 2025, up from $40.0 million at December 31, 2024, primarily due to successful at-the-market (ATM) equity offerings.
• Net proceeds from ATM offerings totaled $120.4 million for the nine months ended September 30, 2025, and an additional $42.0 million from October 1 to November 6, 2025.
• Net loss increased to $12.4 million for the nine months ended September 30, 2025, compared to $7.9 million for the same period in 2024, driven by higher operating expenses.
• Research and development (R&D) expenses rose by 66% to $5.3 million for the nine months ended September 30, 2025, reflecting increased activity at Idaho National Laboratory (INL) and other projects.
• General and administrative (G&A) expenses increased by 61% to $9.2 million for the nine months ended September 30, 2025, largely due to higher professional fees and stock-based compensation.
• Interest income more than doubled to $2.1 million for the nine months ended September 30, 2025, benefiting from higher cash balances invested in treasury bills and savings.
• The company successfully loaded Lightbridge Fuel material samples into the INL Advanced Test Reactor (ATR) for irradiation testing in October 2025.
• Agreements with INL (CRADA and SPPA) were extended, with the SPPA now lasting 12 years and the CRADA until September 27, 2032, and total estimated cash payments to Battelle Energy Alliance, LLC (BEA) reaching approximately $6.8 million.
• A new agreement with Numerical Advisory Solutions, LLC (NAS) for $0.8 million was signed to develop customized safety-analysis computer codes for Lightbridge Fuel designs, commencing in Q4 2025.
• The Romania feasibility study for CANDU reactors was completed with favorable results, indicating Lightbridge Fuel can double discharged burnup, leading to a new agreement with RATEN ICN for irradiation tests.
• Authorized common shares were increased from 25 million to 100 million on May 8, 2025, to support future capital needs.
• The company anticipates investing approximately $12.0 million in R&D for the full year 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong financial liquidity through successful capital raises, significantly boosting its cash reserves. It also made substantial progress in R&D, extending key national laboratory agreements and achieving important milestones like fuel sample loading for irradiation. While operating losses increased due to heightened R&D and G&A expenses, this reflects active investment in its core technology. The long-term commercialization timeline remains distant, and significant future funding is still required, but current progress and financial health are positive.

Positives

• Significantly strengthened cash position with $153.3 million in cash and cash equivalents as of September 30, 2025, providing strong liquidity for the next 12 months.
• Successful capital raises through ATM offerings, generating $120.4 million net proceeds in the first nine months of 2025 and an additional $42.0 million post-quarter.
• Key R&D milestones achieved, including the successful loading of Lightbridge Fuel material samples into the INL Advanced Test Reactor for irradiation testing.
• Extended and expanded agreements with Idaho National Laboratory (INL) for long-term fuel development, demonstrating continued government and national lab support.
• Favorable results from the Romania feasibility study, indicating Lightbridge Fuel's potential to double discharged burnup in CANDU reactors, leading to further testing agreements.
• Initiated a new $0.8 million contract with Numerical Advisory Solutions, LLC (NAS) for safety analysis code development, enhancing internal capabilities for regulatory submissions.
• Increased interest income by 110% for the nine months ended September 30, 2025, due to higher cash balances and effective cash management.
• Ongoing positive evaluations of Lightbridge Fuel by Texas A&M University and MIT, highlighting improved thermal-hydraulic margins, lower operating temperatures, and greater power uprate potential.

Negatives

• Net loss increased to $12.4 million for the nine months ended September 30, 2025, compared to $7.9 million in the prior year, indicating a higher cash burn rate.
• Operating expenses, including G&A and R&D, significantly increased by 63% to $14.5 million for the nine months ended September 30, 2025, contributing to the larger net loss.
• Net cash used in operating activities increased to $8.1 million for the nine months ended September 30, 2025, up from $5.7 million in the prior year, reflecting higher operational costs.
• Significant shareholder dilution occurred with the issuance of approximately 9.9 million common shares through ATM offerings in the first nine months of 2025, and an additional 1.9 million shares post-quarter.
• The company continues to incur significant expenses and operating losses with no anticipated material incoming cash flows from operations in the near term.

Risks

• Ability to commercialize nuclear fuel technology, including risks related to design, testing, and market adoption.
• Dependence on strategic partners for development and commercialization.
• Adverse changes to agreements or relationships with the U.S. government and its national laboratories.
• Ability to fund future operations, including general corporate overhead and R&D expenses, and continue as a going concern.
• Future market and demand for fuel for nuclear reactors and the ability to attract customers.
• Ability to manage the business effectively in a rapidly evolving market.
• Ability to employ and retain qualified employees and consultants with nuclear industry experience.
• Competition and competitive factors in the markets, including from accident tolerant fuels.
• Access to and availability of nuclear test reactors and risks associated with unexpected changes in the nuclear fuel development timeline.
• Access to and availability of adequate resources and manufacturing capabilities at national laboratories affecting development timeline and project costs.
• Increased costs associated with metallization of nuclear fuel.
• Uncertainties related to conducting business in foreign countries.
• Public perception of nuclear energy generally.
• Changes in laws, rules, and regulations governing the business.
• Changes in the political environment.
• Development and utilization of, and challenges to, intellectual property domestically and abroad.
• Volatility in the trading price of securities, potentially leading to substantial losses for purchasers.
• Need for additional funding and/or in-kind support via strategic alliances, government grants, commercial loans, or further equity/debt offerings to support future R&D activities.
• Disruption in access to INL's resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges.
• Inherent uncertainties associated with the ATM program, including potential declines in stock price, fluctuations in trading volume, adverse market conditions, or regulatory changes.
• Potential for significant dilution to existing stockholders from additional share issuances through the ATM program.
• Failure to obtain adequate funding on acceptable terms in the future could significantly delay or prevent the advancement of the nuclear fuel development program.

Future Outlook

The company anticipates continued significant R&D activities, with an estimated investment of $12.0 million for the full year 2025. Key milestones include producing samples and rodlets for INL testing, developing and validating modeling codes, creating a Fuel Qualification Plan, preparing an NRC Engagement Plan, and advancing manufacturing efforts for co-extrusion and pilot-scale fuel fabrication. Thermal-hydraulic analysis and experiments are also planned. Commercialization of nuclear fuel assemblies, including demonstration of lead test rods and/or assemblies in commercial reactors, is expected in the 2030s, with initial purchase orders 15-20 years from now. Potential factors that could accelerate this timeline include expedited testing through advanced modeling, early strategic partnerships for fabrication, streamlined regulatory pathways (e.g., ADVANCE Act), and supportive federal policies for next-generation nuclear technology.

Management Comments

• We believe that the world's energy needs and climate goals can only be met if nuclear power's share of the energy-generating mix grows substantially in the coming decades.
• We believe Lightbridge can benefit from a growing nuclear power industry, and that our nuclear fuel can help enable that growth to happen.
• We believe our metallic fuel will offer significant economic and safety benefits over traditional nuclear fuel, primarily because of the superior heat transfer properties and the resulting lower operating temperature of our all-metal fuel.
• The increased projected power need for data centers is driving large tech companies to invest in nuclear power, which in turn is driving utilities to seek ways to increase power output of existing nuclear plants and to explore deploying new plants.
• We expect that Lightbridge Fuel can provide water-cooled SMRs with the same benefits our technology brings to large reactors, with such benefits being even more meaningful to the economic case for deployment of SMRs, including potential load following capability.
• We anticipate entering into additional Project Task Statements and/or modifications to the existing PTS under the SPPA and/or CRADA with INL to expand the scope of work.

Industry Context

The company operates within the growing nuclear power industry, which is experiencing renewed interest driven by global climate goals and increasing energy demands from sectors like data centers. The development of advanced nuclear fuels, including accident-tolerant fuels and those for Small Modular Reactors (SMRs), is a key trend. Lightbridge's focus on metallic fuel with superior heat transfer properties aligns with the industry's need for enhanced safety, improved economics (e.g., power uprates), and proliferation resistance. The collaboration with national laboratories like INL and engagement with entities like Oklo, Inc. (developing advanced micro-reactors) positions Lightbridge within the forefront of next-generation nuclear technology development, aiming to capitalize on the anticipated growth in nuclear energy's share of the energy mix.

Comparison to Industry Standards

• Lightbridge Fuel demonstrated improved thermal-hydraulic margins, lower operating temperatures, and greater potential for power uprates compared to conventional fuel, according to preliminary safety evaluation results presented by MIT at the TopFuel 2024 Conference.
• The Romania Feasibility Study indicated that Lightbridge Fuel can double the discharged burnup in a CANDU reactor at U-235 enrichment levels of less than 3% compared to conventional uranium dioxide fuel, suggesting significant performance advantages.

Management Changes

Corporate Governance

Related Party Transactions

• On February 27, 2025, the company issued one share of Series X Preferred Stock to the chair of the Audit Committee (an independent member of the Board) for $100 cash. This share was redeemed for $100 cash after the Annual Meeting on May 8, 2025. The Series X Preferred Stock was used to facilitate the vote on increasing authorized common shares.

Stakeholder Impact

• **Shareholders**: Experience significant dilution due to ongoing ATM equity offerings, but benefit from a strengthened cash position and continued R&D progress aimed at long-term value creation. Increased operating losses may concern some, while the long-term potential of the fuel technology offers upside.
• **Employees/Consultants**: Benefit from increased stock-based compensation, including new restricted stock awards and performance-based awards, aligning their incentives with company milestones. Continued R&D activities provide job security and opportunities.
• **Customers (Future)**: Potential future customers (utilities, SMR operators) stand to benefit from Lightbridge Fuel's promised economic and safety advantages, such as power uprates and improved thermal-hydraulic margins, once commercialized.
• **Government/Regulatory Bodies**: Continued collaboration with U.S. national laboratories (INL) and engagement with the NRC are crucial for fuel development and regulatory approval, aligning with national energy and security goals.
• **Strategic Partners**: Existing and potential partners (e.g., Oklo, Inc., RATEN ICN, NAS) are engaged in various collaborations, indicating mutual interest in advancing nuclear fuel technology and potential future commercialization.

Next Steps

• Produce samples, coupons, and rodlets necessary for testing under INL agreements, leading to casting and extrusion of fuel material samples and their subsequent insertion for irradiation testing in the ATR.
• Continue development and/or validation (benchmarking) of Lightbridge-specific methods and modifications to existing modeling codes to accurately predict Lightbridge Fuel performance.
• Develop a Fuel Qualification Plan describing the approach to characterizing and validating fuel rod, assembly, and component performance, and validating modeling tools.
• Prepare and submit the Nuclear Regulatory Commission (NRC) Engagement Plan outlining engagement with the NRC for license applications.
• Continue manufacturing efforts to establish a manufacturing process for co-extrusion of cladded rodlets for loop irradiation testing and other fuel testing.
• Complete site selection and begin deployment of a Lightbridge Expandable Fuel Fabrication Facility with capacity to produce fuel samples, coupons, rodlets, and full-length fuel rods.
• Perform thermal-hydraulic modeling of Lightbridge Fuel to prepare for a series of thermal-hydraulic experiments to confirm pressure drop, critical heat flux performance, and other parameters.
• Engage early with relevant nuclear regulators to inform future R&D activities.
• Begin demonstration of lead test rods and/or lead test assemblies with metallic fuel in commercial reactors in the 2030s.
• Begin receiving purchase orders for initial fuel reload batches from utilities 15-20 years from now, with deployment approximately two years thereafter.
• Numerical Advisory Solutions, LLC (NAS) will develop customized safety-analysis computer codes, models, and documentation, with an estimated completion window between October 2026 through January 2027.
• RATEN ICN will conduct scoping studies (Phase 1) to develop preliminary experiment designs, evaluate infrastructure, and obtain cost/schedule estimates for potential new driver fuel, followed by Phase 2 implementation for irradiation tests.

Key Dates

Recommendation

Lightbridge Corporation has significantly bolstered its cash reserves through successful ATM offerings, providing a strong liquidity runway for its intensive R&D efforts. The company is making tangible progress in its nuclear fuel development, evidenced by the loading of fuel samples for irradiation testing at INL and positive preliminary results from external studies. Key agreements with national laboratories have been extended, signaling continued support for its long-term projects. However, the company continues to incur substantial operating losses and cash burn, and the commercialization timeline for its fuel remains distant (2030s and beyond), requiring significant future capital raises that will likely lead to further shareholder dilution. Given the high-risk, long-term nature of nuclear fuel development, coupled with the current cash position and R&D progress, a 'hold' recommendation is appropriate. Investors should monitor R&D milestones, future funding needs, and progress towards regulatory approvals, as these will be critical determinants of long-term value.

Keywords

Nuclear Fuel Technology, Advanced Nuclear Fuel, Lightbridge Fuel, Idaho National Laboratory, INL, ATR, CANDU Reactors, SMRs, Small Modular Reactors, Uranium-Zirconium Alloy, Fuel Fabrication, Irradiation Testing, SEC Filing, 10-Q, Financial Results, R&D, Capital Raise, ATM Offering, Stock-Based Compensation, Corporate Governance